What is Twinlab Consolid's earnings per share (EPS)?

Twinlab Consolid (TLCC) reported diluted earnings per share of $-0.04 for fiscal year 2024. This represents a 20.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Twinlab Consolid Financials

TLCC

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2024 Currency USD FYE December

This page shows Twinlab Consolid (TLCC) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 12 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 7/100

Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Twinlab Consolid has an operating margin of -15.2%, meaning the company retains $-15 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is down from -10.2% the prior year.

Growth

Twinlab Consolid's revenue declined 14.3% year-over-year, from $13.6M to $11.7M. This contraction results in a growth score of 9/100.

Liquidity

Twinlab Consolid's current ratio of 0.03 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 0/100, which could limit financial flexibility.

Cash Flow

While Twinlab Consolid generated -$273K in operating cash flow, capex of $2K consumed most of it, leaving -$275K in free cash flow. This results in a low score of 19/100, reflecting heavy capital investment rather than weak cash generation.

Piotroski F-Score Weak

2/9

Twinlab Consolid passes 2 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Earnings Quality Low Quality

0.03x

For every $1 of reported earnings, Twinlab Consolid generates $0.03 in operating cash flow (-$273K OCF vs -$9.5M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk

-0.2x

Twinlab Consolid earns $-0.2 in operating income for every $1 of interest expense (-$1.8M vs $8.0M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$11.7M

YoY-14.3%

5Y CAGR-30.8%

10Y CAGR-15.3%

Twinlab Consolid generated $11.7M in revenue in fiscal year 2024. This represents a decrease of 14.3% from the prior year.

EBITDA

-$1.8M

YoY-30.5%

Twinlab Consolid's EBITDA was -$1.8M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 30.5% from the prior year.

Net Income

-$9.5M

YoY+30.7%

Twinlab Consolid reported -$9.5M in net income in fiscal year 2024. This represents an increase of 30.7% from the prior year.

EPS (Diluted)

$-0.04

YoY+20.0%

Twinlab Consolid earned $-0.04 per diluted share (EPS) in fiscal year 2024. This represents an increase of 20.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow

-$275K

YoY-109.5%

Twinlab Consolid generated -$275K in free cash flow in fiscal year 2024, representing cash available after capex. This represents a decrease of 109.5% from the prior year.

Cash & Debt

$13K

YoY-31.6%

5Y CAGR-45.5%

10Y CAGR-29.6%

Twinlab Consolid held $13K in cash against $0 in long-term debt as of fiscal year 2024.

Dividends Per Share

N/A

Shares Outstanding

N/A

Margins & Returns

Gross Margin

33.7%

YoY-3.2pp

5Y CAGR+18.4pp

10Y CAGR+17.2pp

Twinlab Consolid's gross margin was 33.7% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is down 3.2 percentage points from the prior year.

Operating Margin

-15.2%

YoY-5.0pp

5Y CAGR+37.5pp

10Y CAGR+4.6pp

Twinlab Consolid's operating margin was -15.2% in fiscal year 2024, reflecting core business profitability. This is down 5.0 percentage points from the prior year.

Net Margin

-81.4%

YoY+19.3pp

5Y CAGR-20.9pp

10Y CAGR-47.0pp

Twinlab Consolid's net profit margin was -81.4% in fiscal year 2024, showing the share of revenue converted to profit. This is up 19.3 percentage points from the prior year.

Return on Equity

N/A

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

$2K

5Y CAGR-36.9%

10Y CAGR-43.6%

Twinlab Consolid invested $2K in capex in fiscal year 2024, funding long-term assets and infrastructure.

TLCC Income Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Revenue	$11.7M-14.3%	$13.6M-20.9%	$17.2M-76.1%	$72.1M+8.7%	$66.3M-9.7%	$73.5M
Cost of Revenue	$7.7M-10.1%	$8.6M-4.6%	$9.0M-83.7%	$55.5M+0.1%	$55.5M-10.9%	$62.3M
Gross Profit	$3.9M-21.7%	$5.0M-38.8%	$8.2M-50.6%	$16.6M+52.4%	$10.9M-2.7%	$11.2M
R&D Expenses	N/A	N/A	N/A	N/A	$1K-97.1%	$35K
SG&A Expenses	$5.2M0.0%	$5.2M-24.8%	$7.0M-28.4%	$9.7M-33.3%	$14.6M-39.7%	$24.2M
Operating Income	-$1.8M-27.9%	-$1.4M+22.1%	-$1.8M+76.8%	-$7.7M-42.2%	-$5.4M+86.0%	-$38.8M
Interest Expense	$8.0M-3.3%	$8.3M+4.7%	$7.9M-8.2%	$8.6M-3.8%	$9.0M-9.3%	$9.9M
Income Tax	$43K0.0%	$43K+72.0%	$25K+92.3%	$13K-65.8%	$38K-51.9%	$79K
Net Income	-$9.5M+30.7%	-$13.7M-66.8%	-$8.2M+45.0%	-$14.9M-3.8%	-$14.4M+67.7%	-$44.5M
EPS (Diluted)	$-0.04+20.0%	$-0.05-66.7%	$-0.03+50.0%	$-0.060.0%	$-0.06+66.7%	$-0.18

Metric	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23
Revenue	$3.5M+48.8%	$2.3M-25.5%	$3.1M+12.6%	$2.8M-11.9%	$3.1M-14.5%	$3.7M+20.2%	$3.1M-18.2%	$3.7M
Cost of Revenue	$2.2M+33.3%	$1.7M-11.2%	$1.9M-1.9%	$1.9M-9.5%	$2.1M-9.1%	$2.3M+25.5%	$1.9M-17.3%	$2.3M
Gross Profit	$1.2M+89.4%	$642K-47.6%	$1.2M+45.8%	$841K-17.0%	$1.0M-23.9%	$1.3M+11.9%	$1.2M-19.6%	$1.5M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$2.2M+71.8%	$1.3M+42.6%	$885K-4.5%	$927K-19.1%	$1.1M-3.8%	$1.2M-4.1%	$1.2M-25.2%	$1.7M
Operating Income	-$1.1M-43.0%	-$746K-439.1%	$220K+220.2%	-$183K+73.2%	-$684K-238.6%	-$202K+33.8%	-$305K-54.0%	-$198K
Interest Expense	$2.1M+5.7%	$2.0M-0.4%	$2.0M-1.0%	$2.0M+8.0%	$1.8M-12.6%	$2.1M-4.4%	$2.2M+4.2%	$2.1M
Income Tax	$37K	$0-100.0%	$6K	$0-100.0%	$12K-52.0%	$25K+316.7%	$6K	$0
Net Income	-$3.1M-17.5%	-$2.7M-70.4%	-$1.6M+25.0%	-$2.1M-35.3%	-$1.5M+71.1%	-$5.4M-34.4%	-$4.0M-42.0%	-$2.8M
EPS (Diluted)	N/A	$-0.010.0%	$-0.010.0%	$-0.01	N/A	$-0.020.0%	$-0.02-100.0%	$-0.01

TLCC Balance Sheet

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Total Assets	$6.0M-33.0%	$9.0M-57.0%	$20.9M-15.9%	$24.9M-28.8%	$35.0M+15.0%	$30.4M
Current Assets	$4.6M-18.5%	$5.7M-62.4%	$15.1M-12.9%	$17.4M+0.1%	$17.3M+6.4%	$16.3M
Cash & Equivalents	$13K-31.6%	$19K-97.8%	$866K-76.1%	$3.6M+756.4%	$424K+57.0%	$270K
Inventory	$2.5M-28.0%	$3.4M-50.4%	$6.9M+18.1%	$5.8M-7.7%	$6.3M-4.1%	$6.6M
Accounts Receivable	$2.0M-2.2%	$2.1M+70.3%	$1.2M-82.3%	$6.9M-18.3%	$8.4M+32.8%	$6.3M
Goodwill	N/A	N/A	N/A	$0-100.0%	$8.8M0.0%	$8.8M
Total Liabilities	$154.5M+4.4%	$148.0M+1.2%	$146.2M+3.0%	$142.0M+3.5%	$137.1M+16.0%	$118.1M
Current Liabilities	$154.5M+6.0%	$145.8M+2.6%	$142.2M+4.0%	$136.8M+3.6%	$132.0M+11.8%	$118.1M
Long-Term Debt	$0	$0	$0	$0-100.0%	$476K	N/A
Total Equity	-$148.5M-6.8%	-$139.0M-10.9%	-$125.3M-7.0%	-$117.1M-14.6%	-$102.1M-16.4%	-$87.8M
Retained Earnings	-$379.6M-2.6%	-$370.1M-3.8%	-$356.4M-2.4%	-$348.2M-4.5%	-$333.3M-4.5%	-$318.9M

Metric	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23
Total Assets	$6.0M-21.2%	$7.6M+4.9%	$7.3M-11.1%	$8.2M-8.8%	$9.0M-5.0%	$9.5M-31.4%	$13.8M-18.2%	$16.9M
Current Assets	$4.6M-7.2%	$5.0M+17.1%	$4.3M-15.3%	$5.0M-11.5%	$5.7M-0.4%	$5.7M-39.1%	$9.4M-17.8%	$11.4M
Cash & Equivalents	$13K-7.1%	$14K-94.7%	$265K+90.6%	$139K+631.6%	$19K-62.0%	$50K-64.8%	$142K+40.6%	$101K
Inventory	$2.5M-11.2%	$2.8M+15.2%	$2.4M-34.5%	$3.7M+7.5%	$3.4M-22.7%	$4.4M-19.7%	$5.5M-26.5%	$7.5M
Accounts Receivable	$2.0M+9.9%	$1.8M+52.7%	$1.2M+12.7%	$1.1M-48.3%	$2.1M+106.2%	$1.0M-64.5%	$2.8M+18.2%	$2.4M
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$154.5M+1.0%	$153.0M+2.0%	$150.0M+0.4%	$149.3M+0.9%	$148.0M+0.7%	$146.9M+0.7%	$145.9M+0.6%	$145.0M
Current Liabilities	$154.5M+1.9%	$151.6M+2.2%	$148.3M+0.6%	$147.4M+1.1%	$145.8M+1.1%	$144.2M+0.9%	$142.9M+1.2%	$141.3M
Long-Term Debt	$0	$0	$0	$0	$0	$0	$0	$0
Total Equity	-$148.5M-2.2%	-$145.4M-1.9%	-$142.7M-1.1%	-$141.1M-1.5%	-$139.0M-1.1%	-$137.5M-4.1%	-$132.1M-3.1%	-$128.1M
Retained Earnings	-$379.6M-0.8%	-$376.5M-0.7%	-$373.8M-0.4%	-$372.2M-0.6%	-$370.1M-0.4%	-$368.6M-1.5%	-$363.2M-1.1%	-$359.2M

TLCC Cash Flow Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Operating Cash Flow	-$273K-109.4%	$2.9M+167.2%	-$4.3M-262.8%	$2.6M+152.3%	-$5.1M+39.7%	-$8.4M
Capital Expenditures	$2K	$0-100.0%	$99K-36.1%	$155K+675.0%	$20K0.0%	$20K
Free Cash Flow	-$275K-109.5%	$2.9M+165.7%	-$4.4M-276.8%	$2.5M+149.0%	-$5.1M+39.6%	-$8.4M
Investing Cash Flow	-$2K	$0+100.0%	-$99K	N/A	N/A	-$20K
Financing Cash Flow	$269K+107.2%	-$3.7M-327.3%	$1.6M+131.3%	$712K-86.4%	$5.2M+112.0%	$2.5M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23
Operating Cash Flow	-$907K-177.4%	-$327K-134.8%	$941K+4605.0%	$20K-98.8%	$1.7M+707.7%	$208K-72.8%	$766K+215.2%	$243K
Capital Expenditures	N/A	N/A	N/A	N/A	$0	$0	$0	$0
Free Cash Flow	N/A	N/A	N/A	N/A	$1.7M+707.7%	$208K-72.8%	$766K+215.2%	$243K
Investing Cash Flow	N/A	N/A	N/A	N/A	$0	N/A	N/A	N/A
Financing Cash Flow	$908K+1094.7%	$76K+109.3%	-$815K-915.0%	$100K+105.8%	-$1.7M-474.2%	-$298K+58.9%	-$725K+28.2%	-$1.0M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

TLCC Financial Ratios

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Gross Margin	33.7%-3.2pp	36.8%-10.8pp	47.6%+24.6pp	23.0%+6.6pp	16.4%+1.2pp	15.2%
Operating Margin	-15.2%-5.0pp	-10.2%+0.2pp	-10.4%+0.3pp	-10.7%-2.5pp	-8.2%+44.6pp	-52.8%
Net Margin	-81.4%+19.3pp	-100.7%-52.9pp	-47.8%-27.1pp	-20.7%+1.0pp	-21.7%+38.9pp	-60.6%
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	-157.7%-5.2pp	-152.5%-113.1pp	-39.3%+20.8pp	-60.1%-18.9pp	-41.2%+105.3pp	-146.4%
Current Ratio	0.030.0	0.04-0.1	0.11-0.0	0.130.0	0.130.0	0.14
Debt-to-Equity	0.000.0	0.000.0	0.000.0	0.000.0	-0.00+1.3	-1.35
FCF Margin	-2.4%-23.6pp	21.3%+46.9pp	-25.6%-29.1pp	3.5%+11.1pp	-7.7%+3.8pp	-11.5%

Metric	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23
Gross Margin	35.2%+7.5pp	27.7%-11.7pp	39.3%+8.9pp	30.4%-1.8pp	32.2%-4.0pp	36.2%-2.7pp	38.9%-0.7pp	39.6%
Operating Margin	-30.9%+1.3pp	-32.1%-39.2pp	7.1%+13.7pp	-6.6%+15.1pp	-21.8%-16.3pp	-5.5%+4.5pp	-10.0%-4.7pp	-5.3%
Net Margin	-91.1%+24.3pp	-115.4%-65.0pp	-50.4%+25.3pp	-75.7%-26.4pp	-49.3%+96.7pp	-145.9%-15.4pp	-130.5%-55.4pp	-75.1%
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	-52.3%-17.2pp	-35.1%-13.5pp	-21.6%+4.0pp	-25.6%-8.3pp	-17.2%+39.4pp	-56.7%-27.8pp	-28.9%-12.3pp	-16.6%
Current Ratio	0.030.0	0.030.0	0.030.0	0.030.0	0.040.0	0.04-0.0	0.07-0.0	0.08
Debt-to-Equity	0.000.0	0.000.0	0.000.0	0.000.0	0.000.0	0.000.0	0.000.0	0.00
FCF Margin	N/A	N/A	N/A	N/A	53.4%+47.8pp	5.7%-19.4pp	25.1%+18.6pp	6.5%

Note: Shareholder equity is negative (-$148.5M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.03), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Bioadaptives BDPTD

$72K

Komo Plant Based Foods Inc KOMOF

$117K

Plantfuel Life Inc PLFLF

$180K

R-Three Technolo RRRT

$87K

North Amer Frac Sand Inc NAFS

$216K

Frequently Asked Questions

What is Twinlab Consolid's annual revenue?

Twinlab Consolid (TLCC) reported $11.7M in total revenue for fiscal year 2024. This represents a -14.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Twinlab Consolid's revenue growing?

Twinlab Consolid (TLCC) revenue declined by 14.3% year-over-year, from $13.6M to $11.7M in fiscal year 2024.

Is Twinlab Consolid profitable?

No, Twinlab Consolid (TLCC) reported a net income of -$9.5M in fiscal year 2024, with a net profit margin of -81.4%.

What is Twinlab Consolid's EBITDA?

Twinlab Consolid (TLCC) had EBITDA of -$1.8M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Twinlab Consolid have?

As of fiscal year 2024, Twinlab Consolid (TLCC) had $13K in cash and equivalents against $0 in long-term debt.

What is Twinlab Consolid's gross margin?

Twinlab Consolid (TLCC) had a gross margin of 33.7% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.

What is Twinlab Consolid's operating margin?

Twinlab Consolid (TLCC) had an operating margin of -15.2% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.

What is Twinlab Consolid's net profit margin?

Twinlab Consolid (TLCC) had a net profit margin of -81.4% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

What is Twinlab Consolid's free cash flow?

Twinlab Consolid (TLCC) generated -$275K in free cash flow during fiscal year 2024. This represents a -109.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Twinlab Consolid's operating cash flow?

Twinlab Consolid (TLCC) generated -$273K in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

What are Twinlab Consolid's total assets?

Twinlab Consolid (TLCC) had $6.0M in total assets as of fiscal year 2024, including both current and long-term assets.

What are Twinlab Consolid's capital expenditures?

Twinlab Consolid (TLCC) invested $2K in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.

What is Twinlab Consolid's current ratio?

Twinlab Consolid (TLCC) had a current ratio of 0.03 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.

What is Twinlab Consolid's debt-to-equity ratio?

Twinlab Consolid (TLCC) had a debt-to-equity ratio of 0.00 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Twinlab Consolid's return on assets (ROA)?

Twinlab Consolid (TLCC) had a return on assets of -157.7% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

What is Twinlab Consolid's cash runway?

Based on fiscal year 2024 data, Twinlab Consolid (TLCC) had $13K in cash against an annual operating cash burn of $273K. This gives an estimated cash runway of approximately 1 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Why is Twinlab Consolid's debt-to-equity ratio negative or unusual?

Twinlab Consolid (TLCC) has negative shareholder equity of -$148.5M as of fiscal year 2024, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is Twinlab Consolid's Piotroski F-Score?

Twinlab Consolid (TLCC) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Twinlab Consolid's earnings high quality?

Twinlab Consolid (TLCC) has an earnings quality ratio of 0.03x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Twinlab Consolid cover its interest payments?

Twinlab Consolid (TLCC) has an interest coverage ratio of -0.2x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Twinlab Consolid?

Twinlab Consolid (TLCC) scores 7 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.